Table 3 In vitro susceptibility to antibiotics alone (first row or column) or in combination (other rows/columns) on the infectious agents isolated either from non-nosocomial ascitic fluids after exclusion of coagulase negative staphylococci (upper right half) or from confirmed spontaneous bacterial peritonitis (including coagulase negative staphylococci , lower left half)
n = 84 | amoxicillin | amoxicillin-clavulanate | Piperacillin-tazobactam | Third generation cephalosporin | Fluoro-quinolone | Aminoglycosides | Cotrimoxazole | Glycopeptide | |
|---|---|---|---|---|---|---|---|---|---|
n = 57 | |||||||||
- | 47.6% | 63.1% | 65.5% | 54.8% | 57.1% | 50.0% | 47.6% | 50.0% | |
Amoxicillin | 40.4% | - | - | 77.4% | 78.6% | 82.1% | 77.4% | 69.0% | |
Amoxicillin-clavulanate | 43.9% | - | - | - | 81.0% | 83.3% | 81.0% | 78.6% | |
Piperacillin-tazobactam | 47.4% | - | - | - | 79.8% | 79.8% | 78.6% | 85.7% | |
Third generation cephalosporin | 33.3% | 56.1% | - | - | 72.6% | 69.0% | 69.0% | 84.5% | |
Fluoroquinolone | 38.6% | 61.4% | 61.4% | 61.4% | 49.1% | - | 65.5% | 84.5% | |
Aminoglycosides | 47.4% | 73.7% | 73.7% | 68.4% | 56.1% | - | 66.7% | - | |
Cotrimoxazole | 29.8% | 57.9% | 57.9% | 57.9% | 45.6% | 49.1% | 47.3% | 78.6% | |
Glycopeptide | 50.9% | 71.9% | 71.9% | 80.7% | 77.2% | 84.2% | - | 73.3% | |